368 related articles for article (PubMed ID: 10920190)
21. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
22. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
Bauer JH; Liu KD; You Y; Lai SY; Goldsmith MA
J Biol Chem; 1998 Apr; 273(15):9255-60. PubMed ID: 9535918
[TBL] [Abstract][Full Text] [Related]
23. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
25. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
Wasik MA; Nowak I; Zhang Q; Shaw LM
Leuk Lymphoma; 1998 Feb; 28(5-6):551-60. PubMed ID: 9613985
[TBL] [Abstract][Full Text] [Related]
26. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of IFN-gamma signaling by glucocorticoids.
Hu X; Li WP; Meng C; Ivashkiv LB
J Immunol; 2003 May; 170(9):4833-9. PubMed ID: 12707366
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
29. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
Chida D; Wakao H; Yoshimura A; Miyajima A
Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
[TBL] [Abstract][Full Text] [Related]
33. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
Migone TS; Lin JX; Cereseto A; Mulloy JC; O'Shea JJ; Franchini G; Leonard WJ
Science; 1995 Jul; 269(5220):79-81. PubMed ID: 7604283
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.
Lee IH; Li WP; Hisert KB; Ivashkiv LB
J Exp Med; 1999 Nov; 190(9):1263-74. PubMed ID: 10544198
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs.
Sudarshan C; Galon J; Zhou Y; O'Shea JJ
J Immunol; 1999 Mar; 162(5):2974-81. PubMed ID: 10072548
[TBL] [Abstract][Full Text] [Related]
36. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
37. Ultraviolet radiation inhibits interleukin-2-induced tyrosine phosphorylation and the activation of STAT5 in T lymphocytes.
Kulms D; Schwarz T
J Biol Chem; 2001 Apr; 276(16):12849-55. PubMed ID: 11278301
[TBL] [Abstract][Full Text] [Related]
38. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.
Cohney SJ; Sanden D; Cacalano NA; Yoshimura A; Mui A; Migone TS; Johnston JA
Mol Cell Biol; 1999 Jul; 19(7):4980-8. PubMed ID: 10373548
[TBL] [Abstract][Full Text] [Related]
39. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
40. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway.
Miyazaki T; Takaoka A; Nogueira L; Dikic I; Fujii H; Tsujino S; Mitani Y; Maeda M; Schlessinger J; Taniguchi T
Genes Dev; 1998 Mar; 12(6):770-5. PubMed ID: 9512511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]